Boya Lei
Impact in
- Ophthalmology top 5%
- Ocular Diseases and Behçet’s Syndrome
- Retinal Diseases and Treatments
- Retinal and Optic Conditions
- Ocular Infections and Treatments
- Intraocular Surgery and Lenses
-
- interferon and immune responses
Papers in
-
- Ocular Diseases and Behçet’s Syndrome 8
-
- Retinal and Macular Surgery 5
- Co-authors
- Ruiping Gu (16 shared papers)Gezhi Xu (11 shared papers)Wenyi Tang (7 shared papers)Xinyi Ding (6 shared papers)Rui Jiang (9 shared papers)Jun Ma (2 shared papers)Min Zhou (4 shared papers)Chen Jiang (1 shared paper)
- Journals
- Retina (4 papers)Investigative Ophthalmology & Visual Science (3 papers)Eye (2 papers)BMC Ophthalmology (2 papers)Ocular Immunology and Inflammation (2 papers)
- Partner nations
- ChinaOmanUnited States
In The Last Decade
Boya Lei
23 papers receiving 270 citations
Peers
Comparison fields: 5 of 52
- Ophthalmology 121
- Immunology 52
- Radiology, Nuclear Medicine and Imaging 40
- Nephrology 11
- Cancer Research 19
Countries citing papers authored by Boya Lei
This map shows the geographic impact of Boya Lei's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Boya Lei with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Boya Lei more than expected).
Fields of papers citing papers by Boya Lei
This network shows the impact of papers produced by Boya Lei. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Boya Lei. The network helps show where Boya Lei may publish in the future.
Co-authors
The 25 scholars most cited alongside Boya Lei, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 36 | |
| 2 | MicroRNA-29b-3p inhibits cell proliferation and angiogenesis by targeting VEGFA and PDGFB in retinal microvascular endothelial cells. | 2020 | 27 |
| 3 | 2017 | 24 | |
| 4 | 2018 | 20 | |
| 5 | 2017 | 20 | |
| 6 | 2019 | 19 | |
| 7 | 2022 | 18 | |
| 8 | 2018 | 17 | |
| 9 | 2018 | 14 | |
| 10 | 2020 | 13 | |
| 11 | 2021 | 12 | |
| 12 | 2017 | 11 | |
| 13 | 2018 | 8 | |
| 14 | 2023 | 7 | |
| 15 | 2021 | 6 | |
| 16 | 2022 | 6 | |
| 17 | 2019 | 5 | |
| 18 | 2018 | 4 | |
| 19 | 2022 | 2 | |
| 20 | 2024 | 1 |
About Boya Lei
Boya Lei is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging, Rheumatology, Immunology and Infectious Diseases, having authored 29 papers that have together received 273 indexed citations. Recurring topics across this work include Ocular Diseases and Behçet’s Syndrome (8 papers), Retinal and Macular Surgery (5 papers), Systemic Lupus Erythematosus Research (3 papers), Antifungal resistance and susceptibility (1 paper), Mosquito-borne diseases and control (1 paper), Polyomavirus and related diseases (1 paper), Lymphoma Diagnosis and Treatment (1 paper) and Inflammasome and immune disorders (1 paper). The work is most often cited by research in Ophthalmology (121 citations), Immunology (52 citations), Radiology, Nuclear Medicine and Imaging (40 citations), Nephrology (11 citations) and Cancer Research (19 citations). Boya Lei has collaborated with scholars based in China, Oman and United States. Frequent co-authors include Ruiping Gu, Gezhi Xu, Wenyi Tang, Xinyi Ding, Gezhi Xu, Rui Jiang, Jun Ma, Min Zhou, Chen Jiang and Min Zhou. Their work appears in journals such as Retina, Investigative Ophthalmology & Visual Science, Eye, BMC Ophthalmology and Ocular Immunology and Inflammation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.